Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» vaccines
vaccines
Pfizer takes Poland to court over alleged missed COVID-19 vaccine payments
Pfizer takes Poland to court over alleged missed COVID-19 vaccine payments
Fierce Pharma
Pfizer
vaccines
COVID-19
Poland
Flag link:
WHO authorizes emergency use of Novavax's updated COVID shot
WHO authorizes emergency use of Novavax's updated COVID shot
Reuters
Novavax
WHO
COVID-19
vaccines
Flag link:
Merck strides onto Pfizer’s turf, posting pivotal vaccine data and heading to regulators
Merck strides onto Pfizer’s turf, posting pivotal vaccine data and heading to regulators
Fierce Pharma
Merck
Pfizer
vaccines
clinical trials
pneumococcal disease
V116
Prevnar 20
Flag link:
European Patent Office declares Moderna mRNA patent invalid
European Patent Office declares Moderna mRNA patent invalid
Reuters
Moderna Therapeutics
MRNA
patents
BioNTech
Pfizer
vaccines
Europe
Flag link:
Is Novavax, the latecomer COVID vaccine, worth the wait?
Is Novavax, the latecomer COVID vaccine, worth the wait?
Medical Marketing and Media
Novavax
vaccines
COVID-19
Flag link:
Japan to buy 1.4 mln doses of Daiichi Sankyo COVID vaccine
Japan to buy 1.4 mln doses of Daiichi Sankyo COVID vaccine
Reuters
Japan
Daiichi Sankyo
COVID-19
vaccines
Flag link:
Valneva single-dose chikungunya vaccine poised to ‘revolutionize’ global health
Valneva single-dose chikungunya vaccine poised to ‘revolutionize’ global health
Biopharma Reporter
Valneva
vaccines
Ixchiq
FDA
chikungunya virus
Flag link:
IO Biotech concludes subject enrollment in melanoma vaccine trial
IO Biotech concludes subject enrollment in melanoma vaccine trial
Clinical Trials Arena
IO Biotech
clinical trial
melanoma
vaccines
Flag link:
FDA approves Valneva's chikungunya vaccine
FDA approves Valneva's chikungunya vaccine
Reuters
Valneva
vaccines
chikungunya virus
FDA
Ixchiq
Flag link:
Novavax posts higher-than-expected revenue, says prepared to further cut costs
Novavax posts higher-than-expected revenue, says prepared to further cut costs
Reuters
Novavax
earnings
vaccines
COVID-19
Flag link:
Moderna's Stock Just Tumbled 12%. Here's Why It's Still a Buy.
Moderna's Stock Just Tumbled 12%. Here's Why It's Still a Buy.
Motley Fool
Moderna Therapeutics
vaccines
COVID-19
Flag link:
RSV is on the rise but preventative drugs are in short supply
RSV is on the rise but preventative drugs are in short supply
MIT Technology Review
RSV
CDC
vaccines
nirsevimab
drug shortages
AstraZeneca
Flag link:
Moderna takes hefty $1.3B COVID write-off, scales back manufacturing as sales shrink
Moderna takes hefty $1.3B COVID write-off, scales back manufacturing as sales shrink
Fierce Pharma
Moderna Therapeutics
earnings
vaccines
COVID-19
Flag link:
GSK outpaces Pfizer in RSV vaccine market
GSK outpaces Pfizer in RSV vaccine market
BioPharma Dive
GSK
Pfizer
vaccines
RSV
Arexvy
Abrysvo
Flag link:
Pfizer RSV vaccine gets off to fast start on market
Pfizer RSV vaccine gets off to fast start on market
BioPharma Dive
Pfizer
RSV
vaccines
Abrysvo
Flag link:
A continuing decline in sales of COVID-19 products clips revenue at Pfizer
A continuing decline in sales of COVID-19 products clips revenue at Pfizer
Yahoo Finance
Pfizer
earnings
COVID-19
vaccines
Paxlovid
Flag link:
Pfizer's mRNA flu vaccine hits primary goals in phase 3 trial, but secondary miss raises questions
Pfizer's mRNA flu vaccine hits primary goals in phase 3 trial, but secondary miss raises questions
Fierce Biotech
Pfizer
vaccines
clinical trials
MRNA
Flu
Flag link:
Moderna joins CEPI's 100 Days Mission to advance pandemic preparedness
Moderna joins CEPI's 100 Days Mission to advance pandemic preparedness
Fierce Biotech
Moderna Therapeutics
MRNA
CEPI
vaccines
pandemic
Flag link:
Pfizer, BioNTech prep flu-COVID mRNA combo shot for phase 3, reprising Moderna race after seeing early data
Pfizer, BioNTech prep flu-COVID mRNA combo shot for phase 3, reprising Moderna race after seeing early data
Fierce Biotech
Pfizer
BioNTech
Moderna Therapeutics
vaccines
MRNA
flu-COVID combo vaccines
Flag link:
Araclon vaccine appears to slow Alzheimer's in exploratory phase 2 analysis, spurring review of next steps
Araclon vaccine appears to slow Alzheimer's in exploratory phase 2 analysis, spurring review of next steps
Fierce Biotech
Araclon
Grifols
Alzheimer's disease
clinical trials
vaccines
ABvac40
Flag link:
Pages
1
2
3
4
5
6
7
8
9
…
next ›
last »